About Elevation Oncology, Inc. 
Elevation Oncology, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 15 Schemes (12.2%)
Foreign Institutions
Held by 21 Foreign Institutions (7.6%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2025)
Net Profit:
-14 Million
Pharmaceuticals & Biotechnology
USD 22 Million ()
NA (Loss Making)
NA
0.00%
-1.06
-95.46%
0.46






